Download PDF
Thromb Haemost 1978; 40(02): 574-576
DOI: 10.1055/s-0038-1648695
Letter to the Editor
Schattauer GmbH Stuttgart

Thrombogenic Potential of Factor IX Concentrates: Comparison of Tests

Sarah M Middleton
University Department of Medicine, Royal Infirmary, Glasgow G4 OSF, Scotland
,
Charles D Forbes
University Department of Medicine, Royal Infirmary, Glasgow G4 OSF, Scotland
,
Colin R M Prentice
University Department of Medicine, Royal Infirmary, Glasgow G4 OSF, Scotland
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Breckenridge RI, Ratnoff OD. 1965; The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin is converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor Protamine Sulphate and Hexadimethrine Journal of Clinical Investigation 44: 302
    CrossrefPubMedGoogle Scholar
  • 2 Kingdom HS, Lundblad RL, Veltkamp JJ, Aronson DL. 1975; Potentially thrombogenic materials in factor IX concentrates. Thrombosis et Diathesis Haemorrhagica 33: 617
    PubMedGoogle Scholar
  • 3 Pepper DS, Banhaygi D, Howie A, Cash JD. 1977; In vitro thrombogenicity tests of factor IX concentrates. British Journal of Haematology 36: 555
    PubMedGoogle Scholar
  • 4 Prowse CV, Pepper DS, Cash JD, Patterson M. 1977; Thrombogenicity screening of factor IX concentrates. Thrombosis and Haemostasis 38: 728
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Sas G, Owren RE, Smith JK, Middleton SM, Cash JD. 1975; In vitro spontaneous thrombin generation in human factor IX concentrates. British Journal of Haematology 31: 25
    CrossrefPubMedGoogle Scholar